The United States requires pharmaceutical companies that they include prices in their ads



[ad_1]

Breaking News Emails

Receive last minute alerts and special reports. News and stories that matter, delivered the mornings of the week.

Pharmaceutical companies will have to give current prices of their products in TV commercials as part of a new proposal from the Trump administration released Monday.

The new rule, which is open to discussion, would affect any drug covered by Medicare or Medicaid.

Health and Social Services Secretary Alex Azar announced the new proposal just hours after the lobby group representing major pharmaceutical companies announced that its members would begin indirectly to mention the awards in their television commercials.

PhRMA (Pharmaceutical Research and Manufacturers of America) said its 33 member companies would direct viewers to websites listing the advertised price of drugs they advertise, as well as what consumers can actually expect to pay for these drugs. .

"The consumer TV commercials of PhRMA member companies will soon be directing patients to information about drug costs, including the price of the drug, reimbursable fees, or any other context regarding the potential cost of the drug and the cost of the drug. 39, financial assistance available. , "Said the group in a statement.

Azar said it was not a coincidence that PhRMA had announced this initiative on Monday. They knew that the Trump administration was getting ready to act, he said.

"We appreciate their efforts, but putting information on a website does not amount to correcting it in an advertisement," said Azar in a speech at the National Academy of Medicine.

"For too long, the price of drugs has not been compared to any other market," he said. "We will not wait for an industry with so many contradictory and perverse incentives to reform."

Under the proposed rule, a company should set in writing the price of a typical treatment for drugs such as antibiotics or the cost of 30 days for drugs used in the treatment of chronic diseases such as l 39; hypertension or diabetes.

PhRMA said any attempt to force companies to publish their prices would violate the First Amendment's free expression rights.

[ad_2]
Source link